Last updated 4 years ago
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
400 patients around the world
Available in Argentina
This is a multicenter, randomized, double-blind, placebo-controlled trial assessing the use a
nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 disease in
health-workers.
Ariel Dogliotti
1Research sites
400Patients around the world
This study is for people with
Covid-19
Covid 19 prophylaxis
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- physician, nurses, and physical therapist who usually attend hospitalized COVID19 patients.No more than 48 hours since he/she assisted a COVID-19 patientAble to understand and give written informed consent
- Participation in any other clinical trial of an experimental treatment for COVID-19Not having a cell phone with WhatsApp for remote monitoringHypersensitivity or known allergy to any component of the productPregnancy or lactation
Sites
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
StudyCARR-COV-02
SponsorAriel Dogliotti
Study typeInterventional
Conditions
Covid 19 prophylaxis
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04521322
